| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 05/06/2009 | EP1443961B1 Glycoprotein compositions |
| 05/06/2009 | EP1385506B1 Acylated piperidine derivates as melanocortin-4 receptor agonists |
| 05/06/2009 | EP1240900B1 Factor viii or von willebrand factor for the treatment of hemorrhagic diseases associating thrombopathy |
| 05/06/2009 | CN101426792A Pyrazolopyrimidines as therapeutic agents |
| 05/06/2009 | CN101426768A Sulfonamide compounds useful as adg receptor modulators |
| 05/06/2009 | CN101426763A Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 05/06/2009 | CN101426511A Chemically-modified progenipoietin conjugates |
| 05/06/2009 | CN101423500A Substituted benzoxazoles and analogues as estrogenic agents |
| 05/06/2009 | CN101422601A Preparation method and new use of human middle factor Midkine |
| 05/06/2009 | CN101422592A Traditional Chinese medicine oral liquid for treating broiler ascites syndrome |
| 05/06/2009 | CN101422456A Medicine combination drop-pills and preparation method and quality detection method thereof |
| 05/06/2009 | CN100485385C Chinese medicine preparation for nourishing yin and blood, its preparation process and quality control method |
| 05/06/2009 | CN100485021C Natural animal essence muskrat fragrant active component, preparation technology and its use |
| 05/06/2009 | CN100484935C Benzimidazole-derivatives as factor Xa inhibitors |
| 05/06/2009 | CN100484569C Medicament for mobilizing pluripotent stem cells from tissue into peripheral blood |
| 05/06/2009 | CN100484568C Antibiosis usage of a family of protein |
| 05/06/2009 | CN100484531C Donkey-hide gelatin oral preparation and its making method |
| 05/06/2009 | CN100484417C Health care bamboo salt and its preparing method |
| 05/05/2009 | US7528124 1,3-dihydro-2H-indol-2-one derivative |
| 05/05/2009 | US7528104 Peptides that bind to the erythropoietin receptor |
| 04/30/2009 | WO2009054439A1 Pai-1 production inhibitor |
| 04/30/2009 | WO2009053628A2 Novel compounds, preparation and uses thereof |
| 04/30/2009 | WO2008134445A3 Platelet activation receptor clec-2: compositions and uses thereof |
| 04/30/2009 | US20090111839 Process for Preparing Amorphous Rosuvastatin Calcium of Impurities |
| 04/30/2009 | US20090111806 Azaquinolone based compounds exhibiting prolyl hydroxylase Inhibitory activity, compositions, and uses thereof |
| 04/30/2009 | US20090111769 Antithrombotic Compound |
| 04/30/2009 | US20090111751 Method of Removing a Non-Metallic Protein Inhibitor From a Liquid Pharmaceutical Preparation |
| 04/30/2009 | US20090110683 Monoclonal antibodies against activated protein c |
| 04/30/2009 | US20090110675 Use of platelet activating factor acetylhydrolase as biomarker for anaphylaxis |
| 04/30/2009 | CA2703494A1 Inhibitor of pai-1 production |
| 04/29/2009 | EP2053061A1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
| 04/29/2009 | EP2053039A1 Novel crystal of 5-aminolevulinic acid phosphate and process for production thereof |
| 04/29/2009 | EP2052713A2 Soluble FcgammaR fusion proteins and methods of use thereof |
| 04/29/2009 | EP2051975A2 Substituted prolinamides, production thereof and their use as drugs |
| 04/29/2009 | EP1791813B1 Pentafluorosulfanylphenyl-substituted benzoylguanidines, method for the production thereof, their use as a medicament or diagnostic agent, and a medicament containing these compounds |
| 04/29/2009 | EP1720844B1 Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases |
| 04/29/2009 | EP1660482B1 3-[(2-{ 4-(hexyloxycarbonylamino-imino-methyl)-phenylamino] -methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino -propionic acid ethyl ester methane sulphonate and use thereof as a medicament |
| 04/29/2009 | EP1218509B1 Fibroblast growth factor-like polypeptides |
| 04/29/2009 | CN101421242A Dicarboxamide derivatives |
| 04/29/2009 | CN101420946A Tamsulosin-containing percutaneous absorption type preparation |
| 04/29/2009 | CN101417997A Inhibitor compounds containing benzo2-aminoimidazloe skeleton and preparation method thereof |
| 04/29/2009 | CN101417152A Local vascular delivery of mtor inhibitors in combination with peroxisome proliferators-activated receptor stimulators |
| 04/29/2009 | CN101417119A Medicament composition and package for fast reducing uric acid in blood and use of anserine for fast reducing uric acid in blood |
| 04/29/2009 | CN101417105A Zedoary turmeric oil glucose injection and preparation method thereof |
| 04/29/2009 | CN101417103A Traditional Chinese medicine formulation for treating hyperplasia prostate |
| 04/29/2009 | CN101417064A Traditional Chinese medicine combination for treating gynecology blood disease and preparation method thereof |
| 04/29/2009 | CN101417044A Preparation method Kwangtung purple beautyberry extract and new use thereof |
| 04/29/2009 | CN101417037A Rhinoceros-horn rehmannia-root medicine for treating albumosemia |
| 04/29/2009 | CN101416999A Traditional Chinese medicine formulation for treating cerebrovascular disease |
| 04/29/2009 | CN101416991A Traditional Chinese medicine preparation for treating cerebrovascular disease and preparation technique thereof |
| 04/29/2009 | CN101416982A Preparation method of external natural carbonate emergency life-saving hemostat |
| 04/29/2009 | CN101416943A Ozagrel liposomes and preparation method thereof |
| 04/29/2009 | CN101416939A Puerarin liquid formulation and preparation method thereof |
| 04/29/2009 | CN100482664C 1,5-disubstituted-3,4-dihydro-1H-pyrimido [4,5-D] pyrimidi-2-one compounds and their use in treating CSBP/P38 kinase mediated diseases |
| 04/29/2009 | CN100482276C Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 04/29/2009 | CN100482272C Dry heat processing stabilizer for prothrombin complex or factor v a IX preparation |
| 04/29/2009 | CN100482271C External-use preparation of Chinese medicine for treating ascites |
| 04/29/2009 | CN100482233C Compositions and methods for treating amyloidosis |
| 04/29/2009 | CN100482222C Usage of 1H-indole-2, 3-diketone and its derivant in the process for preparing anemia treating medicine and medicine for treating anemia |
| 04/28/2009 | US7524871 Thrombin inhibitors |
| 04/28/2009 | US7524858 Substituted pyrroline kinase inhibitors |
| 04/28/2009 | US7524852 Bicyclic pyrimidine derivatives |
| 04/28/2009 | US7524517 Methods and compositions for P2X receptor calcium entry channels and other calcium entry mechanisms |
| 04/28/2009 | US7524500 Method of stimulating stem cells |
| 04/28/2009 | CA2472954C Aza-arylpiperazines |
| 04/23/2009 | WO2009052310A1 A3 adenosine receptor antagonists |
| 04/23/2009 | WO2009051718A2 Calcium receptor modulating agents |
| 04/23/2009 | WO2009049961A2 New no-donor aspirin derivatives |
| 04/23/2009 | WO2009049917A1 Kit ligand for use in the treatment of beta-thalassaemia |
| 04/23/2009 | WO2009049370A1 Novel sulfated oligosaccharide derivatives |
| 04/23/2009 | WO2009013915A8 Inhibitor of plasminogen activator inhibitor-1 |
| 04/23/2009 | WO2009011889A4 Compounds and methods for treatment of sickle cell disease or complications associated therewith |
| 04/23/2009 | WO2009004383A3 Aza-bicyclohexane compounds useful as anticoagulants |
| 04/23/2009 | US20090105478 Novel compounds |
| 04/23/2009 | US20090105204 Therapeutic Uses for Aminosterol Compounds |
| 04/23/2009 | US20090105194 Process for the production of a low molecular weight heparin |
| 04/23/2009 | US20090105192 Glycosaminoglycans derived from k5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation |
| 04/23/2009 | US20090105160 Pharmaceutical composition, package and method for rapidly reducing the uric acid in blood |
| 04/23/2009 | US20090104255 Liposome Drug Delivery of Polycyclic, Aromatic, Antioxidant or Anti-Inflammatory Compounds |
| 04/23/2009 | CA2704201A1 Novel sulfated oligosaccharide derivatives |
| 04/23/2009 | CA2702644A1 A3 adenosine receptor antagonists |
| 04/23/2009 | CA2701792A1 Calcium receptor modulating agents |
| 04/23/2009 | CA2700243A1 New no-donor aspirin derivatives |
| 04/22/2009 | EP2050762A2 Novel polypeptides and nucleic acids encoding the same |
| 04/22/2009 | EP2050751A1 Compounds specific to adenosine A1 and A3 receptors and uses thereof |
| 04/22/2009 | EP2050450A1 1-Piperidine-2-cyanoimino-1,3-dihydro-2H-benzimidazole derivatives as nociceptin analogs with ORL1 modulating activity for the treatment of pain |
| 04/22/2009 | EP1628972B1 INDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
| 04/22/2009 | EP1507529B1 Combination comprising valsartan, amlodipine and hydrochlorothiazide |
| 04/22/2009 | CN101412995A Polyethyleneglycol modified aprotinin and preparation thereof |
| 04/22/2009 | CN101412759A Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation |
| 04/22/2009 | CN101411787A Decoction medicament for treating rectum cancer induced hematochezia |
| 04/22/2009 | CN101411784A Compound oral liquid for tonifying blood containing red skin of peanut and preparation technique |
| 04/22/2009 | CN101411771A Chinese medicine preparation for treating bleeding symptoms and preparation method thereof |
| 04/22/2009 | CN101411748A Salvia root total phenolic acid tablet and preparation method thereof |
| 04/22/2009 | CN101411730A Use of oak extract in preparing medicament for treating epidermis injury of person |
| 04/22/2009 | CN101411713A Compound Nimodipine tablet, and enteric tablet thereof, as well as preparation method thereof |
| 04/22/2009 | CN101411532A Beverage containing natural medicament leaf of Toxicodendron vernicifluum and sealwort compositions and preparation method thereof |
| 04/22/2009 | CN100480375C Human cord blood derived unrestricted somatic stem cells (USSC) |
| 04/21/2009 | US7521450 Inhibitors of kinases |
| 04/21/2009 | US7521417 Method and apparatus for preparing an acellular red blood cell substitute |